LEP and metabolic dysfunction-associated steatotic liver disease: The conflicting results may come from that the baseline serum level of leptin in the present study (median, 11.05 ng/mL) was much lower than previous two studies (median, 26.94 ng/mL in patients with non-alcoholic fatty liver disease and 23.51 ng/mL in patients with type 2 diabetes).